In this work, we aimed to investigate the expression of PD1/PDL1 and TIM3/Gal9 on BM T lymphocytes and leukemia cells (blasts and LSCs) in ALL patients, to investigate their associations and correlations with other clinical and hematological parameters and investigate their impact on response to therapy and survival. This evidence concerns the gene HAVCR2 and leukemia.